Skip to content
Loading...

New target could prevent progression of liver damage to cancer

Photo caption:  Dr. Anatolij Horuzsko, reproductive immunologist in the Georgia Cancer Center and Department of Medicine at the Medical College of Georgia at Augusta University (photo credit: Phil Jones, Senior Photographer, Augusta University) Problems like obesity and alcoholism appear to…

Read more

Viral hepatitis burden in Europe

The HEPAHEALTH Project Report, produced by the European Association for the Study of the Liver (EASL), is the second overview commissioned by EASL on the burden of liver disease in Europe. The report encompasses 35 countries in total: the EU region, Iceland,…

Read more

Predicting the future burden of NAFLD and NASH

While the prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) continues to rise, with both conditions increasingly recognised in primary care and specialist practice, quantifying future disease burden has always been challenging. This is largely due to…

Read more

Focused ultrasound increases drug delivery to liver tumours

A heat-sensitive liposomal preparation loaded with doxorubicin (multiple brands) was able to deliver its contents directly to liver lesions when the temperature was raised above 39.5 °C by focused ultrasound (FUS), according to a report from researchers at the University…

Read more

EASL Schools of Hepatology: The ‘flipped learning’ model

The traditional learning method which is lecture-based focuses primarily on allowing students to absorb knowledge in the classroom by listening and taking notes. Students are then expected to study the acquired material in their own time. In contrast, the ‘flipped learning’…

Read more
Back To Top